You cannot create a Lecturio account without granting permission to use your email address.
Based on our terms and conditions it is not possible to create a Lecturio account without an email address. Lecturio requires a valid email address in order to inform you about important changes and updates (e.g., of our terms and conditions, the status of your course access, etc.).
Mpox represents a significant emerging infectious disease challenge with global health implications, particularly as it expands beyond its historical endemic regions in Central and West Africa. This course explores the evolution of Mpox from its discovery in the Democratic Republic of Congo (DRC) to its emergence as an international public health concern, examining its virology, epidemiology, clinical manifestations, and control strategies through the pioneering work of Professor Jean-Jacques Muyembe and his colleagues. Understanding this zoonotic orthopoxvirus infection is increasingly essential for clinicians worldwide, as changing ecological factors, human mobility, and viral adaptation continue to reshape its transmission dynamics and geographic distribution.
This course builds upon foundational knowledge of microbiology, infectious disease principles, and basic epidemiology, connecting virological characteristics to clinical presentations and public health responses. Students will learn the historical context of Mpox in the DRC, its clinical spectrum ranging from mild to severe manifestations, the genetic evolution driving changing patterns of transmission, and evidence-based approaches to prevention and treatment. The relevance extends beyond infectious disease specialties into primary care, emergency medicine, dermatology, and global health, as early recognition and appropriate management of Mpox cases have significant implications for both individual patients and community spread. Mastering these concepts enables healthcare professionals to contribute effectively to both clinical care and broader public health initiatives addressing this re-emerging pathogen in diverse populations and settings.
Your Educators of course Mpox (Monkeypox): Insights and Challenges
Jean-Jacques Muyembe-Tamfum, MD, PhD
Dr. Jean-Jacques Muyembe-Tamfum is the Director-General of the Institut National de Recherche Biomédicale (INRB) in Kinshasa, Democratic Republic of the Congo. He obtained his Medical Degree from the University of Lovanium (now University of Kinshasa) in 1969, and his Ph.D. in Virology from the University of Leuven, Belgium, in 1973.
In 1976, Dr. Muyembe investigated the first Ebola outbreak in Congo and draw the blood samples to discover a new virus. He led the research for Ansuvimab which has been successfully tested as a treatment for Ebola and approved for use in 2019. Owing to his achievements in Ebola research and outbreak response, he received the Royal Society Africa Prize in 2014 and the Hideyo Noguchi Africa Prize in 2019.
Within Lecturio, Dr. Muyembe-Tamfum shares his knowledge of infectious diseases, specifically Ebola and Mpox.
User reviews
(1)
5,0 of 5 stars
5 Stars
5
4 Stars
0
3 Stars
0
2 Stars
0
1 Star
0
User reviews
(1)
5,0 of 5 stars
5 Stars
5
4 Stars
0
3 Stars
0
2 Stars
0
1 Star
0
Get Premium to add bookmarks
Lecturio Premium gives you full access to all content and features.